Multiphoton endoscope could minimize biopsies
October 18, 2011 By Anne Ju in Medical research
Watt W. Webb, the Samuel B. Eckert Professor in Engineering and co-inventor of multiphoton microscopy, holds his lab's latest multiphoton endoscope prototype. (Jason Koski/University Photography)
(Medical Xpress) -- From precancerous lesions in the bladder to polyps in the colon, pathologists are constantly examining tissue biopsies for diagnoses. Researchers at Cornell are pushing the limits of the well-established imaging technology called multiphoton microscopy by shrinking the microscopes so they can be inserted safely into a patient's body -- and minimizing the need for unnecessary biopsies.
For more than two decades, Watt W. Webb, the Samuel B. Eckert Professor in Engineering and professor of applied and engineering physics, has dreamed of making multiphoton microscopy, which he invented with colleagues in 1990, available in clinical settings to quickly image inside a person's liver, bladder, lung or any other organ. The same technology that uses two-photon excitation to harness cells' intrinsic fluorescence could be housed into the tiny end of a thin endoscope to directly image tissues or tumors.
"The motivation all along was to look at human cells," Webb said.
Webb's lab, in collaboration with Chris Xu, associate professor of applied and engineering physics, is now developing several prototypes of multiphoton endoscopes. The latest -- 4 cm in length and 3 mm in diameter -- is described online in Proceedings of the National Academy of Sciences, Oct. 17.
Multiphoton microscopy acquires high-resolution images deep below the surface of a tissue sample. This allows visualization of cellular details within unstained tissues that would be useful for pathologists to make diagnostic predictions.
The next-generation endoscope could minimize the need for biopsies altogether; doctors would image cancerous lesions in real time and remove only what's necessary. The endoscope would also allow doctors to examine surgical margins at high resolution in real time, potentially improving surgical outcomes.
Other Cornell researchers working on the project are postdoctoral associate Christopher Brown, graduate student David Rivera, senior research associate Dimitre Ouzounov and research associate Ina Pavlova, with assistance from graduate students Nicholas Horton, David Huland and Adam Straub.
Weill Cornell Medical College researchers divert human tissue samples to the multiphoton microscopy lab to take images before sending the samples through normal pathology channels. (Jason Koski/University Photography)
The team collaborates with doctors at Weill Cornell Medical College, who will test the prototypes on human tissue samples. Eventually, with FDA approval, doctors hope the multiphoton endoscope can be used in lieu of, or in tandem with, a traditional low-magnification optical endoscope in the operating room.Three Weill researchers -- Fred Maxfield, professor and chair of biochemistry; Douglas Scherr, urological surgeon and associate professor of urology; and Sushmita Mukherjee, director of multiphoton microscopy and assistant professor of biochemistry -- are co-investigators on a National Institutes of Health-funded research grant, in collaboration with Webb's group, on multiphoton endoscopy. The have published several papers on how multiphoton produces fast, reliable and dye-free tissue imaging of human samples from at least seven organs.
Equipped with two benchtop multiphoton microscopes, the Weill researchers are testing multiphoton capabilities with tissue from patients (who have signed releases) before the tissue is analyzed by traditional pathology methods.
"We not only have the corresponding histology, but also the clinical history of the person, so we know what is going on," said Mukherjee, who runs the lab.
Developing an optical biopsy instrument has been called the "holy grail" for surgical endoscopy -- the ability to get identical histologic information as one would obtain from a surgical biopsy without having to extract the tissue from the patient, Scherr said.
Bladder cancers, in which Scherr specializes, have high rates of recurrence because it is difficult to pinpoint and remove every area of malignancy, he explained.
Even so, 70 percent of all bladder biopsies are benign, Scherr said, because with the naked eye, a surgeon cannot distinguish between an inflammatory and a malignant lesion, so they have to biopsy it all to be safe.
"Multiphoton endoscopy can act as an adjunct to our standard evaluation system and, hopefully, diminish the number of unnecessary biopsies we take," Scherr said.
The collaborations with Webb's group have proven a fruitful partnership that bridges the gap between applied physics laboratory research and clinical settings, Maxfield said. He recalls Webb's many meetings with doctors, starting in about 2005, when he was pitching the endoscope idea.
"It was actually fascinating to have this physicist come and make appointments with surgeons in various specialties," Maxfield said.
Provided by
Cornell University
-
Scientists create 3-D models of whole mouse organs (w/ Video)
Jun 24, 2010 |
not rated yet |
0
-
Robotic surgery extends benefits to bladder cancer patients at NewYork-Presbyterian/Weill Cornell
Jul 30, 2008 |
not rated yet |
0
-
Detecting tumors faster
Jun 04, 2010 |
not rated yet |
0
-
Engineer designs micro-endoscope to seek out early signs of cancer
Nov 19, 2009 |
not rated yet |
0
-
Light-based probe 'sees' early cancers in first tests on human tissue
Mar 26, 2007 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Study reveals new mechanism for estrogen suppression of liver lipid synthesis
By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.
Medical research
May 23, 2013 |
5 / 5 (1) |
0
|
MRI-based measurement helps predict vascular disease in the brain
Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue the journal ...
Medical research
May 23, 2013 |
not rated yet |
0
Antibiotics: A new understanding of sulfonamide nervous system side effects
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
Medical research
May 23, 2013 |
3 / 5 (1) |
0
|
Scientists discover molecule triggers sensation of itch
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
Medical research
May 23, 2013 |
5 / 5 (3) |
0
|
Discarded immune cells induce the relocation of stem cells
Spanish researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today ...
Medical research
May 23, 2013 |
5 / 5 (2) |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Do salamanders hold the solution to regeneration?
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
